Direct measurement of antiviral activities by a novel immunoassay with peroxidase-labeled complement C1q.
A novel immunoassay method for evaluating antiviral activities has been developed. The method involves the specific measurement of viral antigens produced in cells infected with herpes simplex virus (HSV) as a model by using the anti-HSV probe serum to detect HSV antigens and the peroxidase-labeled complement C1q to detect the immune complex formed. A new compound, heteropolyoxotungstate K7[PTi2W10O40]. 6H2O, was proven to have an anti-herpetic activity at the concentration of 5.0 micrograms/ml determined by the novel immunoassay.